
Age-related macular degeneration (AMD) is one of the leading causes of vision loss among adults over the age of 50. While this condition can significantly impact daily life, advancements in eye care are creating new opportunities to manage the disease and help preserve vision. One of the most promising developments is Photobiomodulation (PBM) therapy, an innovative treatment designed to support retinal health in patients with dry macular degeneration.
At Eye Care Associates, we are proud to be the only practice in the area offering this advanced treatment, giving patients access to cutting-edge technology designed to help protect their vision.
Macular degeneration is a progressive eye condition that affects the macula, the central portion of the retina responsible for sharp, detailed vision. The macula allows us to perform tasks that require precision, such as reading, recognizing faces, and driving.
There are two main forms of AMD:
Although there is currently no cure for macular degeneration, early detection and modern treatment options can help slow progression and protect remaining vision.
Photobiomodulation (PBM) therapy is a light-based treatment designed to stimulate retinal cells and improve their function. The therapy uses carefully controlled wavelengths of red, yellow, and near-infrared light that pass through the layers of the retina.
These therapeutic light wavelengths activate the mitochondria within retinal cells. Mitochondria act as the energy generators of the cell, and when they function more efficiently, they can better support the health of critical retinal structures such as the retinal pigment epithelium and photoreceptor cells, both of which play an essential role in maintaining clear vision.
PBM therapy is:
While PBM therapy does not cure macular degeneration, research suggests it may help slow disease progression, support retinal cell function, and in some cases improve visual performance for patients with dry AMD.
Studies investigating PBM therapy for dry AMD have shown encouraging results. Potential benefits may include:
The greatest benefits appear to occur when treatment begins during the mild to moderate stages of dry macular degeneration, before extensive retinal damage has developed.
Because dry AMD develops gradually, many people may not notice symptoms in the early stages. However, early intervention often provides the best opportunity to slow progression and protect vision.
Regular eye exams allow our eye doctors to monitor retinal health and detect subtle changes before vision is significantly affected. If AMD is identified early, therapies like PBM may offer meaningful support in maintaining visual function.
At Eye Care Associates, we are committed to offering the most advanced technologies for protecting and preserving your vision. As the only practice providing Photobiomodulation therapy for dry macular degeneration, we are proud to deliver innovative care that may help patients manage AMD more effectively. Our team carefully evaluates each patient’s retinal health to determine whether PBM therapy may be an appropriate part of their treatment plan.
Schedule a consultation with Eye Care Associates to learn whether PBM therapy may be right for managing AMD and take a proactive step toward protecting your vision. Contact our office in Flagstaff, Arizona, by calling (928) 774-7949 to book an appointment today.